Treatment of ankylosing spondylitis during pregnancy

Treatment of ankylosing spondylitis during pregnancy

Aims of the trial – to study the frequency of drug use in pregnant women with ankylosing spondylitis (AS), to determine the effect of discontinuation of drugs of various groups, as well as the dose of non-steroidal anti-inflammatory drugs (NSAIDs) used, on AS activity during gestation.Material and m...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Krichevskaya, T. V. Dubinina, E. V. Ilinykh, S. I. Glukhova, A. B. Demina
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2021-07-01
Series:	Научно-практическая ревматология
Subjects:	ankylosing spondylitis pregnancy nonsteroidal anti-inflammatory drugs tnf-α inhibitors
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3040
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY
by: T. A. Raskina, et al.
Published: (2016-09-01)

Maternal and neonatal pregnancy outcomes in ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2020-09-01)

CHANGE OF ACTIVITY, FUNCTIONAL CLASS, AND SPINAL MOBILITY IN ANKYLOSING SPONDYLOSIS DURING THERAPY WITH DIFFERENT PHARMACOLOGICAL AGENTS
by: M. Ivanova, et al.
Published: (2014-06-01)

ANKYLOSING SPONDYLITIS AND PREGNANCY: DATA FROM A PILOT STUDY BASED ON A QUESTIONNAIRE SURVEY OF PATIENTS
by: Z. M. Gandaloeva, et al.
Published: (2018-05-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

Renal safety of Long-Term Non-steroidal Anti-inflammatory drugs use in patients with ankylosing spondylitis
by: Young-Eun Kim, et al.
Published: (2025-07-01)

Golimumab in the treatment of extra-skeletal manifestations of ankylosing spondylitis
by: A. B. Demina
Published: (2019-10-01)

IMPACT OF THE THERAPY WITH TUMOR NECROSIS FACTOR α INHIBITORS ON THE FREQUENCY OF UVEITIS EXACERBATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Alla A Godzenko, et al.
Published: (2014-03-01)

Spine inflammatory changes in patients with ankylosing spondylitis assessed by magnetic resonance image
by: A G Bochkova, et al.
Published: (2008-10-01)

Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)

Musculoskeletal losses in patients with ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2019-10-01)

USE OF CAPSULE ENDOSCOPY TO EVALUATE THE EFFECTS OF MELOXICAM AND DICLOFENAC ON THE SMALL BOWEL MUCOSA IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST EXPERIENCE
by: A E Karateev, et al.
Published: (2011-08-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: TATIANA A. Raskina, et al.
Published: (2019-03-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
by: Yu. V. Muravyev, et al.
Published: (2020-05-01)

A Rare Hypersensitivity Reaction with Golimumab: Recurrent Fever After Each Injection
by: Berna Günay, et al.
Published: (2025-08-01)

Technical features and current trends of hip arthroplasty in patients with ankylosing spondylitis
by: I. V. Polevoy, et al.
Published: (2025-04-01)

THE RISK OF CORONARY ARTERY DISEASE DEVELOPMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS (BECHTEREW’S DISEASE) AND PSORIATIC ARTHRITIS: A 10-YEAR PROSPECTIVE FOLLOW-UP STUDY
by: I. Z. Gaidukova, et al.
Published: (2017-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

IMPACT OF THE SPECIFIC FEATURES OF DISEASE COURSE AND THERAPY ON QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: N. A. Kuznetsova, et al.
Published: (2015-03-01)

CHARACTERISTICS OF ADMINISTRATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN ANKYLOSING SPONDYLITIS: CLINICAL OBSERVATION
by: N. A. Shostak, et al.
Published: (2018-06-01)

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: First year results of the LIBRA post-registration safety study
by: Sh. Erdes, et al.
Published: (2024-01-01)

COMMENTS ON THE ARTICLE «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» PUBLISHED IN No4, 2013
by: A. P. Rebrov, et al.
Published: (2014-06-01)

A case of effective use of interleukin 6 inhibitors in patients with ankylosing spondylitis with secondary amyloidosis
by: Sh. F. Erdes, et al.
Published: (2021-08-01)

THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014)
by: Sh. F. Erdes
Published: (2014-09-01)

Ankylosing spondylitis and comorbidity: safety of long-term use of nimesulide
by: R. M. Balabanova
Published: (2018-01-01)

Assessment of spine mobility in patients with ankylosing spondylitis by ultrasound scanning (preliminary data)
by: M. K. Kurbanmagomedov, et al.
Published: (2021-12-01)

Trabecular bone score value in young men with ankylosing spondylitis
by: K. I. Kolpakov, et al.
Published: (2022-09-01)

DIAGNOSIS OF COXITIS IN ANKYLOSING SPONDYLOSIS
by: T. V. Dubinina, et al.
Published: (2016-02-01)

THE DIAGNOSIS AND CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS ACCORDING TO THE DATA OF THE KAZAN CITY RHEUMATOLOGY CENTER
by: L I Myasoutova, et al.
Published: (2012-02-01)

ILIOCAVAL THROMBOSIS WITH A PROXIMAL BORDER TO THE SUPRARENAL SEGMENT OF THE INFERIOR VENA CAVA IN A FEMALE PATIENT WITH ANKYLOSING SPONDYLITIS AND ULCERATIVE COLITIS
by: D. G. Rumyantseva, et al.
Published: (2020-06-01)

PROGRESSION AND OUTCOMES OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDILITIS
by: A. A. Godzenko, et al.
Published: (2014-10-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
by: E. E. Gubar, et al.
Published: (2023-08-01)

THE SEVERE COURSE OF DRUG THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
by: D. G. Rumyantseva, et al.
Published: (2020-04-01)

Detection of Chlamydia pneumoniae in Ankylosing Spondylitis Patients
by: Dunya Fareed Salloom
Published: (2018-03-01)

PROGRESSION OF AORTIC AND VALVULAR HEART DISEASES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2017-10-01)

Axial spondyloarthritis—current aspects
by: Jürgen Braun, et al.
Published: (2024-07-01)

An Actual Insight into the Pathogenic Pathways of Ankylosing Spondylitis
by: Emilia-Daniela Păsăran, et al.
Published: (2024-11-01)

CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION
by: D. A. Poddubnyy, et al.
Published: (2016-01-01)

Influence of Manual Therapy and Stretching Exercises on Mobility Status and Pulmonary Function Tests Among Patients with Ankylosing Spondylitis
by: Daniel Szewczyk, et al.
Published: (2023-11-01)

-->